Vanda Pharmaceuticals Receives FDA Approval, Shares Surge Over 25%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 02 2026
0mins
Source: Benzinga
- FDA Approval Boost: Vanda Pharmaceuticals announced that its NEREUS drug received FDA approval for preventing motion-induced vomiting, leading to a more than 25% surge in share price, which not only enhances market confidence but could significantly increase future revenue.
- Market Sentiment Shift: Despite Vanda's stock surge, overall market sentiment remains weak, with the CNN Fear & Greed Index dropping from 48.4 to 45.8, indicating cautious investor attitudes that may affect the performance of other stocks.
- Decline in Jobless Claims: U.S. initial jobless claims fell by 16,000 to 199,000, below market expectations of 220,000, suggesting resilience in the labor market, which could support economic recovery and influence stock market trends.
- Major Indices Decline: The Dow Jones dropped over 300 points to close at 48,063.29 on Wednesday, while the S&P 500 and Nasdaq Composite also fell by 0.74% and 0.76%, respectively, reflecting market reactions to economic data and overall sentiment, potentially prompting investors to reassess risks.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on FCEL
Wall Street analysts forecast FCEL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FCEL is 9.33 USD with a low forecast of 7.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
0 Buy
3 Hold
1 Sell
Hold
Current: 9.630
Low
7.00
Averages
9.33
High
12.00
Current: 9.630
Low
7.00
Averages
9.33
High
12.00
About FCEL
FuelCell Energy, Inc. is engaged in delivering distributed baseload energy platform solutions through its proprietary fuel cell technology. It develops commercial technologies that produce clean electricity, heat, clean hydrogen, and water. Its commercial product portfolio is based on its carbonate electrochemical platform. Its carbonate electrochemical platform supports power generation and combined heat and power applications using a variety of fuels, including a 50/50 blend of hydrogen and natural gas or biogas blends, biogas, renewable natural gas, and natural gas. It offers its products in different configurations for a range of power and chemical applications, including electricity, hydrogen, heat (including steam), water and carbon-di-oxide (CO2) upgradable to food and beverage grade and/or usable in cement or other industrial products, and to concentrate and separate CO2 from fossil-fueled industrial applications allowing the sequestration and/or utilization of the CO2.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
S&P 500 Rises 0.54% as Tariff Fears Ease, Nasdaq Gains 0.91%
- Market Rebound: The S&P 500 rose 0.54% to 6,912.54 points as President Trump's agreement on a security deal framework with Greenland boosted investor confidence, reflecting a renewed appetite for equities.
- Tech Stock Strength: The Nasdaq Composite gained 0.91% to 23,436.02 points, driven by strong performances from Meta Platforms and Tesla, which rose 5.63% and 4.15% respectively, further extending the tech-led rally.
- Clean Energy Recovery: FuelCell Energy and Enphase Energy surged 6.10% and 12.54% respectively, as the scrapping of new tariffs alleviated pressure on the clean energy sector, prompting renewed investor interest in this area.
- Cautious Investment Advice: Despite the short-term market uplift, analysts advise long-term investors to remain calm and not react impulsively to Trump-related news, as short-term fluctuations should not dictate investment strategies.
Continue Reading
FuelCell Energy (FCEL) Partners with SDCL for 450 MW Power Systems Deployment
- Strategic Collaboration: FuelCell Energy has announced a strategic partnership with Sustainable Development Capital to deploy up to 450 megawatts of advanced power systems, addressing the surging power demands of the global data center market, showcasing the company's proactive positioning in the rapidly evolving AI-driven landscape.
- Technological Edge: The collaboration combines FuelCell's distributed baseload technology with SDCL's expertise in financing and operating scalable energy infrastructure, aiming to provide reliable, always-on power for data centers, enhancing competitiveness in the renewable energy sector while meeting dual demands for sustainability and resilience.
- Market Performance: FuelCell Energy shares surged 8.46% to $8.72 on Tuesday, despite trading approximately 9.1% below its 20-day simple moving average, indicating strong market sentiment and investor confidence in future growth prospects.
- Financial Outlook: The company is expected to report revenues of $47.94 million on March 10, reflecting a 150% year-over-year increase, with an estimated loss of 92 cents per share, demonstrating positive progress in revenue growth and cost management.
Continue Reading